Recognition and prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy
Received:November 30, 2020  
View Full Text  View/Add Comment  Download reader
Key words:cardiomyopathy, hypertrophic  sudden cardiac death  risk  prevention This work was supported by the Preference Funding Project for Science and Technology Activities of Returned Overseas Personnel in Shanxi Province
Author NameAffiliationE-mail
CHEN Liu-Lin First Clinical Medical College, Shanxi Medical University, Taiyuan 030001, China  
HAO Chun-Yan Department of Geriatrics, First Hospital of Shanxi Medical University, Taiyuan 030001, China 
Hits: 84
Download times: 48
      Hypertrophic cardiomyopathy (HCM) is a hereditary cardiomyopathy. Most HCM patients develop mild symptoms throughout their lives. However, they also are at risk of ventricular arrhythmia and sudden cardiac death (SCD), with a prevalence of 80/100000 in Chinese adults, and SCD is the most serious complication. Identifying the risk of SCD in HCM patients can improve their prognosis outcome. In this article, based on the current guidelines and recent studies on HCM and SCD, we review the pathological mechanism, identification of risk factors and prevention of SCD in HCM patients.